Related Experiment Video

Updated: May 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[Targeting cancer antigen (MAGE-A4, NY-ESO -1) for immunotherapy]

Naoko Imai1, Hiroaki Ikeda, Hiroshi Shiku

  • 1Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 25, 2012
PubMed

Insights

Cancer/testis (CT) antigens are promising targets for cancer immunotherapy due to their tumor-specific expression. This review covers the progress of clinical trials targeting MAGE family and NY-ESO-1 antigens.

Area of Science:

  • Immunology
  • Oncology

Context:

  • Cancer/testis (CT) antigens are expressed in various malignant tumors but not in normal adult tissues (except testis).
  • CT antigens are immunogenic and tumor-restricted, making them ideal targets for cancer immunotherapy.
  • Numerous clinical studies have investigated CT antigens as therapeutic targets.

Purpose:

  • To review the history and recent advancements in clinical studies targeting CT antigens.
  • To highlight progress in trials focusing on MAGE family and NY-ESO-1 antigens.

Summary:

  • CT antigens represent a unique class of tumor antigens with significant potential for cancer immunotherapy.
  • Clinical studies targeting MAGE family and NY-ESO-1 have shown promise, with ongoing research and trials.
  • The review encompasses historical perspectives and current progress in the field.

Impact:

  • Provides a comprehensive overview of CT antigen-targeted cancer immunotherapy.
  • Informs future research and clinical development strategies for cancer vaccines and therapies.
  • Underscores the therapeutic potential of targeting MAGE family and NY-ESO-1 in oncology.

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...